PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
19.74%
Net income growth above 1.5x BB's 8.28%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-3.34%
Negative yoy D&A while BB is 2.94%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
69.36%
Some yoy growth while BB is negative at -181.11%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
9.54%
SBC growth while BB is negative at -2.45%. John Neff would see competitor possibly controlling share issuance more tightly.
-89.91%
Negative yoy working capital usage while BB is 182.54%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
188.66%
AR growth of 188.66% while BB is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
16.13%
Inventory growth of 16.13% while BB is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-13233.33%
Negative yoy AP while BB is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-100.26%
Negative yoy usage while BB is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
96.19%
Well above BB's 146.72%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
46.22%
Operating cash flow growth similar to BB's 45.65%. Walter Schloss would see parallel improvements or market conditions in cash generation.
25.59%
CapEx growth well above BB's 8.77%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
-396.73%
Both yoy lines negative, with BB at -19.21%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
-77.70%
Both yoy lines negative, with BB at -17.02%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
30.63%
Below 50% of BB's 105.77%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
148.40%
Growth of 148.40% while BB is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
-20.34%
We reduce yoy invests while BB stands at 23.56%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-26.79%
We cut debt repayment yoy while BB is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
112.45%
Stock issuance far above BB's 44.82%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
-14.59%
Both yoy lines negative, with BB at -7280.53%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.